Antidepressant response associated with pioglitazone: support for an overlapping pathophysiology between major depression and metabolic syndrome.
作者信息
Kemp David E, Ismail-Beigi Faramarz, Calabrese Joseph R
出版信息
Am J Psychiatry. 2009 May;166(5):619. doi: 10.1176/appi.ajp.2008.08081195.
Abstract
摘要
相似文献
1
Antidepressant response associated with pioglitazone: support for an overlapping pathophysiology between major depression and metabolic syndrome.
Am J Psychiatry. 2009 May;166(5):619. doi: 10.1176/appi.ajp.2008.08081195.
2
Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity.
J Affect Disord. 2012 Feb;136(3):1164-73. doi: 10.1016/j.jad.2011.06.033. Epub 2011 Jul 22.
3
[Pioglitazone effects on blood pressure in patients with metabolic syndrome].
Nihon Rinsho. 2008 Aug;66(8):1591-5.
4
Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression.
Psychoneuroendocrinology. 2013 Jun;38(6):767-76. doi: 10.1016/j.psyneuen.2012.08.010. Epub 2012 Sep 19.
5
Double-blind, placebo-controlled trial of pioglitazone for bipolar depression.
J Affect Disord. 2019 Feb 15;245:957-964. doi: 10.1016/j.jad.2018.11.090. Epub 2018 Nov 13.
6
Effects of pioglitazone on metabolic abnormalities, psychopathology, and cognitive function in schizophrenic patients treated with antipsychotic medication: a randomized double-blind study.
Schizophr Res. 2013 Jan;143(1):18-24. doi: 10.1016/j.schres.2012.10.023. Epub 2012 Nov 29.
7
Adjuvant pioglitazone for unremitted depression: Clinical correlates of treatment response.
Psychiatry Res. 2015 Dec 30;230(3):846-52. doi: 10.1016/j.psychres.2015.10.013. Epub 2015 Oct 22.
8
The IRIS III study: pioglitazone improves metabolic control and blood pressure in patients with type 2 diabetes without increasing body weight.
Diabetes Obes Metab. 2007 Jan;9(1):132-3. doi: 10.1111/j.1463-1326.2006.00582.x.
9
Comparison of metabolic profile and adiponectin level with pioglitazone versus voglibose in patients with type-2 diabetes mellitus associated with metabolic syndrome.
Endocr J. 2011;58(6):425-32. doi: 10.1507/endocrj.k10e-327. Epub 2011 Apr 17.
10
Losartan and pioglitazone ameliorate nephropathy in experimental metabolic syndrome rats.
Biol Pharm Bull. 2011;34(5):693-9. doi: 10.1248/bpb.34.693.
引用本文的文献
1
Neurotrophic Factor-α1/Carboxypeptidase E Functions in Neuroprotection and Alleviates Depression.
Front Mol Neurosci. 2022 May 26;15:918852. doi: 10.3389/fnmol.2022.918852. eCollection 2022.
2
PPARγ Dysfunction in the Medial Prefrontal Cortex Mediates High-Fat Diet-Induced Depression.
Mol Neurobiol. 2022 Jul;59(7):4030-4043. doi: 10.1007/s12035-022-02806-6. Epub 2022 Apr 25.
3
Peroxisome proliferator-activated receptor gamma: a novel therapeutic target for cognitive impairment and mood disorders that functions via the regulation of adult neurogenesis.
Arch Pharm Res. 2021 Jun;44(6):553-563. doi: 10.1007/s12272-021-01333-7. Epub 2021 Jun 17.
4
The Novel Role of PPAR Alpha in the Brain: Promising Target in Therapy of Alzheimer's Disease and Other Neurodegenerative Disorders.
Neurochem Res. 2020 May;45(5):972-988. doi: 10.1007/s11064-020-02993-5. Epub 2020 Mar 13.
5
Is There a Future for PPARs in the Treatment of Neuropsychiatric Disorders?
Molecules. 2020 Feb 27;25(5):1062. doi: 10.3390/molecules25051062.
6
Steroid receptor RNA activator affects the development of poststroke depression by regulating the peroxisome proliferator-activated receptor γ signaling pathway.
Neuroreport. 2020 Jan 8;31(1):48-56. doi: 10.1097/WNR.0000000000001367.
7
Acyloxyacyl hydrolase modulates depressive-like behaviors through aryl hydrocarbon receptor.
Am J Physiol Regul Integr Comp Physiol. 2019 Aug 1;317(2):R289-R300. doi: 10.1152/ajpregu.00029.2019. Epub 2019 Apr 24.
8
Targeting the immune system in the treatment of bipolar disorder.
Psychopharmacology (Berl). 2019 Oct;236(10):2909-2921. doi: 10.1007/s00213-019-5175-x. Epub 2019 Feb 13.
9
Therapeutic Strategies for Treatment of Inflammation-related Depression.
Curr Neuropharmacol. 2018 Jan 30;16(2):176-209. doi: 10.2174/1570159X15666170828163048.
10
Pioglitazone could induce remission in major depression: a meta-analysis.
Neuropsychiatr Dis Treat. 2016 Dec 19;13:9-16. doi: 10.2147/NDT.S121149. eCollection 2017.
本文引用的文献
1
Depressive symptoms and metabolic syndrome: is inflammation the underlying link?
Biol Psychiatry. 2008 Nov 15;64(10):896-900. doi: 10.1016/j.biopsych.2008.05.019. Epub 2008 Jul 2.
2
Metabolic syndrome predisposes to depressive symptoms: a population-based 7-year follow-up study.
J Clin Psychiatry. 2008 Feb;69(2):178-82. doi: 10.4088/jcp.v69n0202.
3
Managing psychiatric disorders with antidiabetic agents: translational research and treatment opportunities.
Expert Opin Pharmacother. 2006 Jul;7(10):1305-21. doi: 10.1517/14656566.7.10.1305.
Zotero 插件